More reads
- In bold new proposal, Trump administration pitches an end to certain drug rebates. (STAT)
- FDA warned of EpiPen problems at Pfizer's Meridian factories. (Business Insider)
- European Commission argues pharma deserves further antitrust scrutiny. (STAT Plus)
- In sticking to the knitting has Array given up too much? (EP Vantage)
.png)
No hay comentarios:
Publicar un comentario